Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 38,900 shares, a drop of 6.7% from the March 15th total of 41,700 shares. Based on an average trading volume of 5,200 shares, the short-interest ratio is presently 7.5 days.

Conduit Pharmaceuticals Price Performance

CDTTW opened at $0.06 on Thursday. Conduit Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.18. The company’s fifty day moving average price is $0.07.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility.